{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:46:18Z","timestamp":1788493578643,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1006\/bbrc.2000.3976","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T14:49:19Z","timestamp":1032187759000},"page":"412-419","source":"Crossref","is-referenced-by-count":94,"title":["Inhibition of Human Platelet Aggregation by Nitric Oxide Donor Drugs: Relative Contribution of cGMP-Independent Mechanisms"],"prefix":"10.1006","volume":"279","author":[{"given":"Naoki","family":"Sogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesson S.","family":"Magid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian L.","family":"Megson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bbrc.2000.3976_RF1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.1987.tb11310.x","article-title":"Comparative pharmacology of EDRF, NO and prostacyclin in platelets","volume":"92","author":"Radomski","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1987.tb11367.x","article-title":"The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide","volume":"92","author":"Radomski","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0006-291X(87)80299-1","article-title":"The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium","volume":"148","author":"Radomski","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bbrc.2000.3976_RF4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/bbrc.2000.3976_RF5","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.87.13.5193","article-title":"An L-arginine:nitric oxide pathway present in human platelets regulates aggregation","volume":"87","author":"Radomski","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2000.3976_RF6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: A perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1006\/bbrc.2000.3976_RF7","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(85)91200-7","article-title":"Pharmacology of nitroglycerin and long-acting nitrates","volume":"56","author":"Abrams","year":"1985","journal-title":"Am. J. Cardiol."},{"key":"10.1006\/bbrc.2000.3976_RF8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005344-198001000-00004","article-title":"Comparative effects of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure","volume":"2","author":"Mehta","year":"1980","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(91)90686-4","article-title":"The antiplatelet properties of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders","volume":"18","author":"Stamler","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1006\/bbrc.2000.3976_RF10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1039\/p29960000481","article-title":"Identification of Cu+ as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO)","volume":"2","author":"Dicks","year":"1996","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1006\/bbrc.2000.3976_RF11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1476-5381.1995.tb13317.x","article-title":"Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione","volume":"114","author":"Gordge","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0076-6879(99)01085-X","article-title":"Stability of S-nitrosothiols in presence of copper, zinc-superoxide dismutase","volume":"301","author":"Jourd'heuil","year":"1999","journal-title":"Meth. Enzymol."},{"key":"10.1006\/bbrc.2000.3976_RF13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1172\/JCI118047","article-title":"Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols","volume":"96","author":"Freedman","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1006\/bbrc.2000.3976_RF14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1172\/JCI4890","article-title":"Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide","volume":"103","author":"Zai","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1006\/bbrc.2000.3976_RF15","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1074\/jbc.273.14.7828","article-title":"Xanthine oxidase-mediated decomposition of S-nitrosothiols","volume":"273","author":"Trujillo","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2000.3976_RF16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0968-0896(94)00139-T","article-title":"Chemical mechanism underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-d,l-penicillamine and S-nitrosoglutathione","volume":"3","author":"Askew","year":"1995","journal-title":"Bioorg. Med. Chem."},{"key":"10.1006\/bbrc.2000.3976_RF17","first-page":"526","article-title":"S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide","volume":"284","author":"Liu","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2000.3976_RF18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-199300221-00003","article-title":"Nitric oxide\/nucleophile complexes: A unique class of nitric oxide-based vasodilators","volume":"22","author":"Morley","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/tx960183w","article-title":"Measurement and modeling of nitric oxide release rates for nitric oxide donors","volume":"10","author":"Ramamurthi","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/bbrc.2000.3976_RF20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0701821","article-title":"Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione","volume":"124","author":"Gordge","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF21","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(98)01633-0","article-title":"Inhibition of platelet aggregation by S-nitrosocysteine via cGMP-independent mechanisms: Evidence of inhibition of thromboxane A2 synthesis in human blood platelets","author":"Tsikas","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2000.3976_RF22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"key":"10.1006\/bbrc.2000.3976_RF23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0701940","article-title":"Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BKCa) in smooth muscle cells isolated from the rat mesenteric artery","volume":"124","author":"Mistry","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF24","first-page":"708","article-title":"Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin, and by methylene blue in the rabbit aorta","volume":"232","author":"Martin","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2000.3976_RF25","first-page":"184","article-title":"Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxodiazolo[4,3a]quinoxalin-1-one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/sj.bjp.0701557","article-title":"Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: Potential as a slow release nitric oxide donor drug","volume":"122","author":"Megson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(96)00338-X","article-title":"Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells","volume":"309","author":"Weber","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.97.3.263","article-title":"Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation","volume":"97","author":"Pawloski","year":"1998","journal-title":"Circulation"},{"key":"10.1006\/bbrc.2000.3976_RF29","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1476-5381.1995.tb16404.x","article-title":"The formation of nitric oxide donors from peroxynitrite","volume":"116","author":"Moro","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2000.3976_RF30","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","article-title":"Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2000.3976_RF31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1073\/pnas.89.1.444","article-title":"S-Nitrosylation of proteins with nitric oxide: Synthesis and characterisation of biologically active compounds","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2000.3976_RF32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0008-6363(98)00182-5","article-title":"Nitric oxide-dependent and -independent effects on human platelets treated with peroxynitrite","volume":"40","author":"Brown","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1006\/bbrc.2000.3976_RF33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.1997.sp004066","article-title":"Calcium entry mechanisms in human platelets","volume":"82","author":"Sage","year":"1997","journal-title":"Exp. Physiol."},{"key":"10.1006\/bbrc.2000.3976_RF34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0891-5849(96)00510-2","article-title":"Peroxynitrite-induced tyrosine nitration and phosphorylation in human platelets","volume":"22","author":"Mondoro","year":"1997","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/bbrc.2000.3976_RF35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)01393-0","article-title":"The effect of 1H-[1,2,4]oxadiazolo[4,3,a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide","volume":"785","author":"Onoue","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/bbrc.2000.3976_RF36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0021-9258(18)52393-0","article-title":"Nitric oxide decreases cytosolic free calcium in Balb\/c 3T3 fibroblasts by a cGMP-independent mechanism","volume":"266","author":"Garg","year":"1991","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X00939767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X00939767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T04:21:27Z","timestamp":1620015687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X00939767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0006291X00939767"],"URL":"https:\/\/doi.org\/10.1006\/bbrc.2000.3976","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}